Michael Severino, AbbVie president and soon-to-be Flagship Pioneering CEO-partner
April 13, 2022 10:43 AM EDT
People
Startups
Pharma

Ab­b­Vie pres­i­dent Michael Sev­eri­no heads to Flag­ship as biotech in­cu­ba­tor's third CEO-part­ner in six days

Kyle LaHucik

Senior Reporter

Ab­b­Vie pres­i­dent and vice chair Michael Sev­eri­no is leav­ing the Chica­go-area phar­ma gi­ant on May 31 to be­come a CEO-part­ner at pro­lif­ic biotech cre­ator Flag­ship …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times